Title:
EFFICACY OF AMELIORATING ATOPIC DERMATITIS AND REGULATION OF INTESTINAL MICROBIOME BY USING KESTOSE
Document Type and Number:
WIPO Patent Application WO/2022/146077
Kind Code:
A1
Abstract:
The present invention relates to: a composition comprising kestose as an active ingredient; and use of the composition as an agent to increase the production and/or the content of short chain fatty acids (SCFAs) in the intestines, and for promoting bacteria that produce short chain fatty acids, preventing, treating or ameliorating an inflammatory disease such as atopic dermatitis or intestinal inflammation, and regulating intestinal microbiome. The composition may be a food, pharmaceutical or health functional food composition.
Inventors:
SA SOONOK (KR)
PARK JI WON (KR)
KIH MIN JI (KR)
NAM CHOONG WOO (KR)
HAN JUNG SOOK (KR)
KIM WONYONG (KR)
KIM JONG-HWA (KR)
KIM KIYOUNG (KR)
PARK JI WON (KR)
KIH MIN JI (KR)
NAM CHOONG WOO (KR)
HAN JUNG SOOK (KR)
KIM WONYONG (KR)
KIM JONG-HWA (KR)
KIM KIYOUNG (KR)
Application Number:
PCT/KR2021/020282
Publication Date:
July 07, 2022
Filing Date:
December 30, 2021
Export Citation:
Assignee:
SAMYANG CORP (KR)
International Classes:
A23L33/135; A61K31/702; A61P1/00; A61P17/00
Foreign References:
| EP1878738A1 | 2008-01-16 | |||
| US20190343857A1 | 2019-11-14 | |||
| KR20180122379A | 2018-11-12 | |||
| KR20180078086A | 2018-07-09 |
Other References:
MARKOWIAK-KOPEĆ PAULINA, ŚLIŻEWSKA KATARZYNA: "The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome", NUTRIENTS, vol. 12, no. 4, pages 1107, XP055947528, DOI: 10.3390/nu12041107
Attorney, Agent or Firm:
PANKOREA PATENT AND LAW FIRM (KR)
Download PDF:
Previous Patent: COMPOSITION FOR REDUCING ENDOPLASMIC RETICULUM STRESS
Next Patent: ALLULOSE WITH IMPROVED STABILITY
Next Patent: ALLULOSE WITH IMPROVED STABILITY